Discover How Certain Brains Achieve Remarkable Recovery After Stroke

A well-known actor, treated by stroke specialist Sander Nardai, suffered from a stroke that resulted in aphasia, severely impairing his speech. Nardai noted how devastating this condition can be for any actor.

Fortunately, after three months of recovery, the actor began to articulate a few words, and after a year, he successfully voiced a commercial. Remarkably, he was able to return to live theater. Nardai is affiliated with Semmelweis University, Hungary.

While stories like this inspire hope, many stroke survivors face challenging recovery journeys. A stroke can cause brain damage impairing cognitive and physical functions. Studies show that only about 35% of stroke survivors make a full recovery; most live with significant disabilities such as aphasia, paralysis, and cognitive issues. Stroke is a leading cause of disability globally, affecting nearly 100 million individuals.

The good news is that brain plasticity allows for recovery in many stroke survivors, but the extent can vary. Current research focuses on understanding these differences to enhance recovery strategies.

Understanding Stroke Recovery

A stroke occurs when a blood vessel supplying the brain is interrupted, leading to oxygen deprivation and neuron death. This injury can disrupt essential brain functions, and an inflammatory response can exacerbate the damage.

Factors influencing recovery include age, health history, and the severity of the stroke. According to neurologist Pankaj Sharma from Royal Holloway University of London, even advanced technology struggles to predict outcomes due to the numerous variables at play. Most notable improvements occur within six months, but lasting changes can happen even later. In the acute phase, prompt treatment involves clot-dissolving medications that can reduce long-term impacts, while therapies like speech and physical rehabilitation may further aid recovery.

This recovery mechanism is complex. Although neurons that perish during a stroke cannot be revived, those that survive can form new connections, creating alternate pathways for communication in the brain. As Sharma points out, “new pathways develop to bypass damaged areas.”

Various theories exist about how different brain regions compensate for these deficits, allowing unaffected areas to assume responsibilities of damaged regions, akin to a team taking over for absent members. However, some studies challenge this assumption. One 2021 experiment on mice indicated that damaged neurons could not be replaced by others; instead, rehabilitation might strengthen surviving neurons in the affected region.

Pre-stroke brain health proves crucial for recovery outcomes. Research from Celine Gillebert at the Brain Institute, University of Leuven, revealed that metrics such as brain volume and white matter integrity are strong predictors of post-stroke cognitive function, sometimes even more so than injury location.

People in good cognitive health pre-stroke tend to retain more brain function despite sustained damage, yet educational background can influence outcomes. A 2025 study found that college-educated individuals exhibited greater declines in executive function than those without higher education.

Genetics plays a significant role in stroke recovery as well. In a recent review, Sharma identified several genetic markers, including the APOE4 gene linked to Alzheimer’s, that are associated with poorer recovery outcomes. Conversely, those with certain genetic profiles may demonstrate more robust recovery abilities, such as individuals with CCR5 mutations commonly found in Ashkenazi Jews and other European or West Asian ancestries experiencing exceptional recovery rates.

The Future of Stroke Treatment

Understanding the differences in recovery among stroke survivors who achieve remarkable outcomes, like the actor, is crucial for advancing equitable treatment approaches. Nardai emphasizes that a combination of a healthy pre-stroke brain, timely acute treatment, and consistent rehabilitation contributed to the actor’s impressive recovery. Researchers are now focused on strategies to aid those who are less fortunate.

The significance of the CCR5 mutation is becoming clearer, as mutations appear to provide protective benefits against HIV. This has sparked interest in repurposing HIV medications to replicate the advantages experienced by individuals with beneficial mutations. Initial findings show encouraging potential.

Recent efforts led by Naohiko Okabe and his team at UCLA have identified a drug that may enhance rehabilitative outcomes, at least in mice.

The study involved analyzing the brains of both stroke survivors and engineered mice with similar dysfunctions to understand rehabilitation effects. Successful rehabilitation was associated with increased gamma oscillations—key electrical signals for neuronal communication. Okabe’s research group then sought compounds that could mimic rehabilitation effects by boosting neuron activity responsible for gamma oscillations. Building upon work by Istvan Mody, who developed a gamma ray enhancer for Alzheimer’s treatment, they discovered desirable post-stroke effects in mice. Human trials are the next step, though Okabe cautions that success isn’t guaranteed. Effective medication could provide vital support for those lacking access or capability for rehabilitation.

Exploring how to enhance the brain’s intrinsic healing capabilities is another promising path. Some researchers aim to repurpose established drugs like antidepressants to augment neurotransmitter levels, potentially promoting neuroplasticity. Considering that inflammation can exacerbate stroke damage, existing anti-inflammatory medications are also being evaluated. A team at the University of Manchester, UK, is researching the impact of two anti-inflammatory drugs, including one used for rheumatoid arthritis, to assess their potential in stroke recovery.

Innovative approaches like stem cell therapy are also being investigated. Researchers from the University of Southern California and the University of Zurich reported advancements in using stem cells for stroke treatment to repair the blood-brain barrier and reduce inflammation in animal studies.

A brain-computer interface is emerging as a significant innovation. CorTec, a German company, recently received “Breakthrough Device Designation” for its brain-computer interface designed for stroke rehabilitation. This technology connects the brain with external systems, translating thoughts into actions, enabling recovery of lost functions while potentially rewiring the brain.

Exciting research into psychedelics is generating interest. Johns Hopkins University researchers have initiated human clinical trials using psilocybin, the active component in magic mushrooms, for potential brain growth stimulation. Additionally, a recent study led by Nardai’s team indicated that the psychedelic DMT may protect against cell death, promote rewiring, and mitigate inflammation post-stroke. Nardai proposes the idea of administering DMT during ambulance transport to hospitals to minimize damage, although further studies are essential.

Stroke can be life-changing, yet remarkable recovery is possible, as evidenced by stories like that of the actor. Continued research enhances our understanding of brain recovery, with hopes of extending these benefits to a broader range of stroke survivors.